Original Literature | Model OverView |
---|---|
Publication
Title
Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2.
Affiliation
Division of Infectious Genetics, Department of Microbiology and Immunology,Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Tokyo108-8639, Japan. kmiyake@ims.u-tokyo.ac.jp
Abstract
Toll-like receptors (TLRs) are pathogen recognition molecules that activate theimmune system as part of the innate immune response. Microbial recognition byTLRs plays a crucial role in the host immune system's decision to respond or notto a particular microbial infection. Lipopolysaccharide (LPS), a membraneglycolipid of Gram-negative bacteria, exhibits strong immunostimulating activityamong TLR ligands and has been studied in great detail. Recent studies haveshown that cell surface TLR4-MD-2 physically interacts with LPS and triggers therelease of an LPS signal, revealing a host-pathogen interaction mediated by TLR.
PMID
15051069
|
Entity
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:CD14
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
LBP:sCD14
--
e12
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
TLR4:MD2
--
e13
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
LPS:TLR4:MD2
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m14
0
infinite
0
--
(LPS:TLR4:MD2)n:MYD88
--
e15
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m15
0
infinite
0
--
(LPS:TLR4:MD2)n
--
e16
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m16
0
infinite
0
--
IRAK1
--
e17
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
LPS:TLR4:MD2:MYD88:IRAK1
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
IRAK4
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
LPS:TLR4:MD2:MYD88:IRAK1:IRAK4
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0
infinite
0
--
LPS:TLR4:MD2:MYD88:IRAK1{p}:IRAK4
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m22
0
infinite
0
--
LPS:TLR4:MD2:MYD88:IRAK1{p}:IRAK4:TRAF6
--
e23
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m23
0
infinite
0
--
IkappaBalpha:NFkappaB
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
IkappaBalpha{p}:NF-kappaB
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IkappaBalpha{p}:NF-kappaB
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
NF-kappaB
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
protein remnants
--
e32
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
LPS:TLR4:MD2:TRIF
--
e33
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m36
0
infinite
0
--
LPS:TLR4:MD2:TRAM
--
e34
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m37
0
infinite
0
--
IRF3
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
IRF3{active}
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
NF-kappaB{active}
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
IFN-alpha
--
e38
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m41
0
infinite
0
--
IFN-beta
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m42
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IFN-alpha
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
--
e41
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
--
--
csml-variable:Double
m44
0
infinite
0
--
--
e42
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulumLumen
--
--
--
csml-variable:Double
m45
0
infinite
0
--
--
e43
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
--
csml-variable:Double
m46
0
infinite
0
--
--
e44
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
--
csml-variable:Double
m47
0
infinite
0
--
--
e45
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_Membrane_
--
--
--
csml-variable:Double
m48
0
infinite
0
--
--
e46
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum
--
--
--
csml-variable:Double
m49
0
infinite
0
--
gp96
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m63
0
infinite
0
--
--
e48
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiLumen
--
--
--
csml-variable:Double
m64
0
infinite
0
--
--
e49
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiApparatus
--
--
--
csml-variable:Double
m65
0
infinite
0
--
sCD14
--
e5
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS:LBP:sCD14
--
e6
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e63
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiMembrane
--
--
--
csml-variable:Double
m66
0
infinite
0
--
--
e64
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiTransFace
--
--
--
csml-variable:Double
m67
0
infinite
0
--
TLR4:MD2
--
e65
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
TLR4{gly}:MD2
--
e66
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m69
0
infinite
0
--
TLR4{gly}:MD2
--
e67
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m70
0
infinite
0
--
LPS:MD2
--
e68
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m71
0
infinite
0
--
csml-variable:Double
m72
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
RP105:MD1
--
e70
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m73
0
infinite
0
--
LPS:RP105:MD1
--
e71
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m74
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3985*0.1
nodelay
--
0
PMID: 15051069, 7537731 LPS-binding protein (LBP), a 60 kDa serum glycoprotein that binds to the lipid A moiety of LPS with a dissociation constant of 3.5 nM
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m20*0.1
nodelay
--
0
PMID: 15051069, 11960013 IRAK4 is able to phosphorylate IRAK1.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m22*m183*0.1
nodelay
--
0
PMID: 15051069 IRAK4 is able to phosphorylate IRAK1 [32], which together interact with TRAF6 (TNF receptor-associated factor 6).
p12
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m207*m23*0.1
nodelay
--
0
PMID: 15051069, 12791976 TRAF6 can also lead to the activation of the I¦ÊB¦Á kinase complex (IKK)the phosphorylation and subsequent degradation of I¦ÊB¦Á, and finally the activation of NF-¦ÊBs
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m25*m23*0.1
nodelay
--
0
PMID: 15051069 This then leads to the activation of mitogen-activated protein kinases (MAPKs), such as p38s, ERKs (extracellular signal-regulated kinases) and JNK (c-Jun N-terminal kinase).
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c42 : 1
stoichiometry:c41 : 1
m27*m23*0.1
nodelay
--
0
PMID: 15051069 This then leads to the activation of mitogen-activated protein kinases (MAPKs), such as p38s, ERKs (extracellular signal-regulated kinases) and JNK (c-Jun N-terminal kinase).
p15
p15
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c45 : 1
stoichiometry:c44 : 1
m29*m23*0.1
nodelay
--
0
PMID: 15051069 This then leads to the activation of mitogen-activated protein kinases (MAPKs), such as p38s, ERKs (extracellular signal-regulated kinases) and JNK (c-Jun N-terminal kinase).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m31*m24*0.1
nodelay
--
0
PMID: 15051069, 12791976 TRAF6 can also lead to the activation of the I¦ÊB¦Á kinase complex (IKK)the phosphorylation and subsequent degradation of I¦ÊB¦Á, and finally the activation of NF-¦ÊBs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m32*0.1
nodelay
--
0
PMID: 15051069, 12791976 TRAF6 can also lead to the activation of the I¦ÊB¦Á kinase complex (IKK)the phosphorylation and subsequent degradation of I¦ÊB¦Á, and finally the activation of NF-¦ÊBs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m33*0.1
nodelay
--
0
PMID: 15051069, 12791976 TRAF6 can also lead to the activation of the I¦ÊB¦Á kinase complex (IKK)the phosphorylation and subsequent degradation of I¦ÊB¦Á, and finally the activation of NF-¦ÊBs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m16*m18998*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m6254*0.1
nodelay
--
0
PMID: 15051069 LBP removes LPS from the outer membrane and forms complexes consisting of LPS, LBP and soluble CD14 (sCD14).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m16*m19005*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c61 : 1
m38*m37*m36*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
m34*m36*0.1
nodelay
--
0
PMID: 15051069 The MyD88-independent pathway also activates NF-¦ÊB transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m34*m37*0.1
nodelay
--
0
PMID: 15051069 The MyD88-independent pathway also activates NF-¦ÊB transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m39*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m39*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m93217*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m41*0.1
nodelay
--
0
PMID: 15051069, 12471095, 14556004 Two TIR-containing adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-¦Â (TRIF, also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated to work in concert to activate MyD88-independent activation of IFN regulatory factor 3 (IRF3), leading to the induction of IFN ¦Á/¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c79 : 1
m13*0.1
nodelay
--
0
PMID: 15051069 Toll-like receptor (TLR) 4 associates itself with MD-2 in the endoplasmic reticulum (ER) with the aid of a chaperone gp96 and then undergoes N-linked glycosylation in the Golgi apparatus before cell surface expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m68*0.1
nodelay
--
0
PMID: 15051069 Toll-like receptor (TLR) 4 associates itself with MD-2 in the endoplasmic reticulum (ER) with the aid of a chaperone gp96 and then undergoes N-linked glycosylation in the Golgi apparatus before cell surface expression. PMID: 15051069, 12738639 Human MD-2 is required for human TLR4 glycosylation at residue positions Asn526 and Asn575, without which human TLR4 cannot get to the cell surface, even with MD-2 association.
p3
p3
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m6*m2828*0.1
nodelay
--
0
PMID: 15051069 These complexes deliver LPS to membrane CD14 for LPS signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m69*0.1
nodelay
--
0
PMID: 15051069, 12738639 Human MD-2 is required for human TLR4 glycosylation at residue positions Asn526 and Asn575, without which human TLR4 cannot get to the cell surface, even with MD-2 association.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m21*m155666*0.1
nodelay
--
0
PMID: 15051069, 11500507 Human recombinant soluble MD-2 was shown to interact with LPS at an apparent dissociation constant of 65 nM, which is similar to the dissociation constant for binding of LPS to CD14 (30?74 nM).
p32
p32
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m1632*m6500*0.1
nodelay
--
0
PMID: 15051069, 7897216, 9686597, 11521060 Molecular cloning of MD-2 was preceded by the identification of radioproteictive105 (RP105) and associated MD-1.
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m73*m155666*0.1
nodelay
--
0
PMID: 15051069 RP105?MD-1 is a structurally related complex and has a role in the B cell response to LPS.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
stoichiometry:c78 : 1
stoichiometry:c13 : 1
m3961*m6438*m63*0.1
nodelay
--
0
PMID: 15051069 Toll-like receptor (TLR) 4 associates itself with MD-2 in the endoplasmic reticulum (ER) with the aid of a chaperone gp96. PMID: 15051069, 11593030 Association between human MD-2 and TLR4 occurs in the endoplasmic reticulum (ER).
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c84 : 1
stoichiometry:c88 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m11*m70*0.1
nodelay
--
0
PMID: 15051069 LPS bound to CD14 is transferred to Toll-like receptor (TLR) 4?MD-2, which undergoes oligomerization and triggers a signal. PMID: 15051069, 14517279 A lipid A antagonist, E5531, was shown to block LPS interaction with TLR4?MD-2 probably through direct interaction with TLR4?MD-2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m14*0.1
nodelay
--
0
PMID: 15051069 LPS bound to CD14 is transferred to Toll-like receptor (TLR) 4?MD-2, which undergoes oligomerization and triggers a signal.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m16*m1572*0.1
nodelay
--
0
PMID: 15051069 The TIR domain of MyD88 is important for interaction with the cytoplasmic domain of TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m15*m17*0.1
nodelay
--
0
PMID: 15051069 The death domain of MyD88 recruits members of the (IL)-1 receptor-associated kinases (IRAKs), IRAK1 and IRAK4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m18*m19*0.1
nodelay
--
0
PMID: 15051069 The death domain of MyD88 recruits members of the (IL)-1 receptor-associated kinases (IRAKs), IRAK1 and IRAK4.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--